Navigation Links
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
Date:7/22/2008

rther information, please visit http://www.ariusmabs.com.

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2007 sales by the Pharmaceuticals Division totalled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. Worldwide, the Group employs about 79,000 people. Additional information is available on the Internet at http://www.roche.com.

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Forward-looking statements in this release include, but are not limited to, ARIUS successfully advancing its new product programs as well as licensing opportunities. These statements are only predictions and actual events
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Roche Extends Tender Offer for Ventana
3. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
4. Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitors
5. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. Med Ad News Honors Roche as Company of the Year
8. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
9. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
10. Phase I Results Announced for R1507 From Genmabs Collaboration With Roche
11. Kosan to Reacquire Epothilone Program From Roche

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ision correction experts listed in the Trusted LAS...e recently concluded American Academy of Ophthalmo...alifornia. Dr. Stephen Brint, MD, Dr. Frederick Fr...r Rapoza, MD, Dr. Michael Raizman, MD, Dr. James M...anche, MD, and Dr. Parag Majmudar, MD, all leading...
(Date:11/4/2009)...accine Program must be stopped. Scott Miller and ...l to Arms:2009 Edition" and the one-hour tele... Anthrax Vaccine Story" to inform the public ...overnment science turned into for-profit human ant...s. It is available for world-wide licensing by mo...
(Date:11/4/2009)...swire/ -- Zyngenia, Inc., a privately held biother...dy drug development, today announced that it has s...terprise Associates (NEA), one of the world,s lead...d to create novel, multi-specific antibody-like mo...s with a single agent. The company will initially ...
(Date:11/4/2009)...wswire/ -- Emerson Resources, Inc ., a premier ...that it has formed a strategic partnership with ...hat specializes in the agrichemical and related in...nt capabilities. The exclusive partnership leverag...ook, CEO of Bio Research, who is spearheading Emer...
Breaking Biology Technology:Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4Emerson Resources Forges Strategic Partnership with Bio Research 2
...stCall/ Varian, Inc. (NasdaqGS:,VARI) announced th... Glover,as a new director. Glover is the seventh m...s appointed for a term expiring at the annual meet...r is Senior Vice President, Operations and Chief F...a biopharmaceutical company), a position,he has he...
... Inc.,(Nasdaq: ARNA ) today reported financial re... Total revenues in the first quarter of 2008 were...st quarter of 2007, and included $2.0 million in,r...ent with Siegfried Ltd,and $0.6 million in patent ...rck & Co., Inc. and Ortho-McNeil Pharmaceutical, I...
... Validation Data for Its MISSION(R) ...Sigma-Aldrich(TM) (Nasdaq:,SIAL) and the second ph...unctional validation of the Consortium,s collectio...viral-based shRNA vector constructs.,Currently, mo...ional,validation process. Validated clones coverin...
Other Biology Technology:James T. Glover Appointed to Board of Directors of Varian, Inc. 2Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 2Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 3Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 4Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 5Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 6Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 7Arena Pharmaceuticals Announces First Quarter 2008 Financial Results 8Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 2Sigma-Aldrich Joins Phase 2 of The RNAi Consortium to Validate shRNA Libraries 3
(Date:11/3/2009)... 4, 2009 -- The world,s greatest wines are the re...uman input, and something called the "terroir" -- ...nd climate. , Experts will discuss terroir wit...dnesday, Nov. 4 in Pittsburgh. "Terroir: Winegrap...arts at the 2009 Annual Meetings of the American S...
(Date:11/3/2009)...research report published in a recent issue of Ho...Alegre examined the effects of covering orchard fl...uality, canopy light distribution, orchard tempera...ormed using Extenday and Solarmate films installed...,Mondial Gala, apples. The research showed that th...
(Date:11/3/2009)...TTE, Ind. - Chief executives in 35 of the top Fort... their "ideal salaries" in 2008, according to a ne...e University researcher to determine fair CEO comp...nd corporate governance issues of the day is how t...at Venkatasubramanian, a professor of chemical eng...
Breaking Biology News(10 mins):Great wines come from great soils 2Reflective film can boost profits for apple growers 2New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4AlphaRx and Venturepharm Announce Collaboration Agreement 53597 1AlphaRx and Venturepharm Announce Collaboration Agreement 53597 2Sanofi aventis U S Introduces BenzaClin 28R 29 Carekit 13348 1Sanofi aventis U S Introduces BenzaClin 28R 29 Carekit 13348 2Sanofi aventis U S Introduces BenzaClin 28R 29 Carekit 13348 3Isis Pharmaceuticals to Present at Canaccord Adams 29th Annual Global Growth Conference 53595 1
...by a scientist at Scripps Institution of Oceanogra... fishing,s impact on marine ecosystems. Scripps Oc...nachan accessed archival photographs spanning more...tic decline of so-called "trophy fish" caught arou...n a paper published online in January and printed ...
...n a new, year-long University of Pennsylvania surv...ve methods to train aggressive pets, veterinary re...ll continue to be aggressive unless training techn... current issue of Applied Animal Behavior Science...training methods such as additional exercise or re...
...Centre for Drug Discovery (LSCDD), Singapore,s Nat...ore Institute for Clinical Sciences (SICS), have t...in tumour stem cells. , NNI is one of the instit...e group in Singapore. LSCDD, a wholly owned subsid...i Lilly and Company has recently expanded its faci...
Other Biology News:Historical photographs expose decline in Florida's reef fish, new Scripps study finds 2Historical photographs expose decline in Florida's reef fish, new Scripps study finds 3If you're aggressive, your dog will be too, says veterinary study at University of Pennsylvania 2Singapore research organisations team up to advance drug discovery using brain tumor stem cells 2
Mouse Anti-Verotoxin IIbeta Monoclonal Antibody, Unconjugated, Clone 457 from Santa Cruz Biotechnology, Inc.
... UVS400 is a multi-tasking vacuum source and solve...ated vapor trap and a maintenance-free, oil-free v...o-use, wide-mouth glass condensation flask collect...sy disposal. The UVS400 provides an ideal vacuum s...
Goat Anti-Lysozyme C (W-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
ALTO-8 (Bench top Version) from ABgene
Biology Products: